Microglial activation precedes neuropil loss in AD patients, and recent genome-wide association studies have revealed that microglial genes, such as CD33, TREM2, and HLA-DR, are associated with susceptibility to the late-onset form of the disease (3). The gene discussed is TREM2; the disease is Alzheimer disease.